ATXS
Price
$6.67
Change
-$0.31 (-4.44%)
Updated
Aug 7 closing price
Capitalization
376.42M
3 days until earnings call
RLYB
Price
$0.51
Change
-$0.02 (-3.77%)
Updated
Aug 7 closing price
Capitalization
21.26M
90 days until earnings call
Interact to see
Advertisement

ATXS vs RLYB

Header iconATXS vs RLYB Comparison
Open Charts ATXS vs RLYBBanner chart's image
Astria Therapeutics
Price$6.67
Change-$0.31 (-4.44%)
Volume$216.08K
Capitalization376.42M
Rallybio
Price$0.51
Change-$0.02 (-3.77%)
Volume$324.12K
Capitalization21.26M
ATXS vs RLYB Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. RLYB commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and RLYB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ATXS: $6.67 vs. RLYB: $0.51)
Brand notoriety: ATXS and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 71% vs. RLYB: 23%
Market capitalization -- ATXS: $376.42M vs. RLYB: $21.26M
ATXS [@Biotechnology] is valued at $376.42M. RLYB’s [@Biotechnology] market capitalization is $21.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while RLYB’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 5 bearish.
  • RLYB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ATXS and RLYB are a bad buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а -0.89% price change this week, while RLYB (@Biotechnology) price change was +9.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

RLYB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($376M) has a higher market cap than RLYB($21.3M). ATXS YTD gains are higher at: -25.391 vs. RLYB (-46.771). RLYB has higher annual earnings (EBITDA): -50.26M vs. ATXS (-124.4M). ATXS has more cash in the bank: 295M vs. RLYB (54.5M). RLYB has less debt than ATXS: RLYB (116K) vs ATXS (5.06M). RLYB has higher revenues than ATXS: RLYB (848K) vs ATXS (0).
ATXSRLYBATXS / RLYB
Capitalization376M21.3M1,765%
EBITDA-124.4M-50.26M248%
Gain YTD-25.391-46.77154%
P/E RatioN/AN/A-
Revenue0848K-
Total Cash295M54.5M541%
Total Debt5.06M116K4,365%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSRLYB
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 17 days ago
87%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMS109.50-0.13
-0.12%
GMS
LNG235.27-0.64
-0.27%
Cheniere Energy
EMX3.02-0.03
-0.98%
EMX Royalty Corp
MBUU32.26-0.91
-2.74%
Malibu Boats
VIVK0.95-0.04
-4.37%
Vivakor

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-4.44%
CRNX - ATXS
53%
Loosely correlated
-2.28%
COGT - ATXS
52%
Loosely correlated
-0.82%
DNLI - ATXS
52%
Loosely correlated
-0.42%
XENE - ATXS
52%
Loosely correlated
-1.84%
NRIX - ATXS
50%
Loosely correlated
-3.63%
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PROK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-3.16%
PROK - RLYB
45%
Loosely correlated
-10.94%
PXXLF - RLYB
44%
Loosely correlated
N/A
ATXS - RLYB
38%
Loosely correlated
-4.44%
PRME - RLYB
37%
Loosely correlated
-9.58%
LGVN - RLYB
37%
Loosely correlated
-15.71%
More